1. Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
   Mariusz Dąbrowski, 2021, International Journal of Molecular Sciences CrossRef
2. Allopurinol Suppresses Azoxymethane-Induced Colorectal Tumorigenesis in C57BL/KsJ-db/db Mice
   Junichi Kato et al, 2020, Gastrointestinal Disorders CrossRef
3. Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential
   Min Sun et al, 2024, Frontiers in Pharmacology CrossRef
4. Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice
   Junichi Kato et al, 2020, International Journal of Molecular Sciences CrossRef
5. Comparison between sodium‐glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: A real‐world evidence study
   Hui‐Lin Sung et al, 2024, Diabetes/Metabolism Research and Reviews CrossRef
6. Design, Synthesis, and Evaluation of Glucose Transporter Inhibitor-SN38 Conjugates for Targeting Colorectal Cancer
   Pei-Fang Chiu et al, 2023, Journal of Medicinal Chemistry CrossRef
7. Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents
   Jelena Vekic et al, 2021, International Journal of Molecular Sciences CrossRef